“…Up to now, more than 50 miRNAs are abnormally expressed, leading to alteration in the expression and activity of their targets in PCa, such as miR-21, miR-320, miR-29b and miR34c (Ribas et al, 2009;Hagman et al, 2010;Hsieh et al, 2012;Ru et al, 2012 all prostate carcinoma samples compared with the BPH samples (Porkka et al, 2007;Watahiki et al, 2011). Several studies showed that the potential functions of miR-497 in human breast cancer (Li et al, 2011;Shen et al, 2012), neuroblastoma (Yadav et al, 2011), cervical cancer (Zheng et al, 2012), gastric cancer (Zhu et al, 2012) and colorectal cancer (Guo et al, 2012).…”